MangoRx Acquires Revolutionary Preventive Care Technology from Intramont Technologies
Acquiring Company
Mangoceuticals
Acquired Company
Intramont Technologies
Description
MangoRx has received a Notice of Allowance for Japanese Patent Application No. 2021-545824, originally applied for by Intramont Technologies, Inc. This milestone follows MangoRx’s recent acquisition of the global patent portfolio from Intramont Technologies, expanding its global protection for groundbreaking preventive care technology.
Quick answer
Mangoceuticals is acquiring Intramont Technologies, announced June 4, 2024. Mangoceuticals is based in Dallas, Texas, United States.
- How much did Mangoceuticals pay for Intramont Technologies?
- The deal value was not disclosed.
- What does Mangoceuticals do?
- MangoRX is a new men’s health and wellness company dedicated to developing, marketing, and selling a variety of men’s wellness products and services via a telemedicine platform that connects consumers to licensed..
- Where are Mangoceuticals and Intramont Technologies based?
- Mangoceuticals is based in Dallas, Texas, United States. Intramont Technologies is based in Hackensack, New Jersey, United States.
- Who are the decision-makers at Mangoceuticals?
- Fundz holds 1 contact at Mangoceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Dietary Supplements and Nutrition
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zinzino acquires assets in Xelliss - strategic reinforcement in southern Europe and in the microalgae spirulina (May 12, 2024)
- MangoRx acquires global patent portfolio from Intramont Technologies, Inc. to enter preventive care market (April 25, 2024)
- Zinzino AB (publ) signs letter of intent to acquire Zurvita Inc. to expand distribution power in North America (June 17, 2024)
- CoreFX Ingredients expands portfolio with acquisition of Connoils (May 28, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- Lantheus Holdings, Inc. acquires Meilleur Technologies, Inc. to expand Alzheimer’s diagnostic capabilities (July 15, 2024)
Who to call at Mangoceuticals, and when
When Mangoceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Mangoceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mangoceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mangoceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mangoceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Intramont Technologies?
Intramont Technologies was acquired by Mangoceuticals, based in Dallas. The deal was reported on June 4, 2024. Mangoceuticals is publicly traded (MGRX) and operates in Other.
When did Mangoceuticals acquire Intramont Technologies?
Mangoceuticals's acquisition of Intramont Technologies was reported on June 4, 2024. MangoRx has received a Notice of Allowance for Japanese Patent Application No. 2021-545824, originally applied for by Intramont Technologies, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Intramont Technologies do?
Intramont Technologies, Inc. is the original owner of the global patent portfolio acquired by MangoRx. It is privately held, operating in Biotechnology, and is based in Hackensack.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.